|
Gene Vaccines
5 l: ?; s A h4 UThalhamer, Josef; Weiss, Richard; Scheiblhofer, Sandra (Eds.)
0 n% c. b4 i' \9 q; p3 Z4 O8 @8 G1st Edition., 2012, XI, 330 p. 49 illus., 41 in color.4 s( j# p9 Y. R$ f& _6 }, s
( @4 V0 G' P& P- G' a* VHardcover, ISBN 978-3-7091-0438-5
/ a- j5 k: }" i$ m7 q# [- \Online orders shipping within 2-3 days3 j/ ~# N% V; E4 @
149,95
" r& C8 g( Y/ ?$ [" y9 H& {4 U
: z; G, e! q* M/ l! A' X: K目录2 U8 F; Q( d) b7 v. ]
Preface.- 1 General mechanisms of gene vaccines.- 2 Strategies to Improve DNA Vaccine Potency: HPV-associated Cervical Cancer as a Model System.- 3 Immune-activating mechanisms of replicase-based DNA and RNA vaccines and their role in immune-apoptosis.- 4 Cytokine genes as molecular adjuvants for DNA vaccines.- 5 Pharmaceutical non-viral formulations for gene vaccines.- 6 Rational design of formulated DNA vaccines: the DermaVir approach.- 7 In vivo electroporation.- 8 Electroporation-based Trigrid™ delivery system (TDS) for DNA vaccine administration.- 9 Prime Boost Regimens for Enhancing Immunity: Magnitude, Quality of Mucosal and Systemic Gene Vaccines.- 10 Intranodal genetic immunization.- 11 Immunotherapy of cancer with RNA vaccines.- 12 DNA and RNA vaccines for prophylactic and therapeutic treatment of type I allergy.- 13 Approved veterinary vaccines – paving the way to products for human use.- 14 Current status of regulations for DNA vaccines.- 15 State of the art production of antibiotic resistance-free plasmid DNA.- 16 Industrial Manufacturing of Plasmid-DNA Products for Gene Vaccination and Therapy.8 v+ U Y1 S6 H
( R0 y7 w7 Q, Y# X. S下载地址:
) i. p `5 @# U2 P* w1 f7 e2 Z* j2 p5 P) N t
1 P( j! o% C* z/ U4 Z; @' X0 o |
|